Live
SUDARSCHEM logoSUDARSCHEMstock

Sudarshan Chemical Industries Ltd

₹899.6
-0.74%
Open
₹906.35
High
₹921
Low
₹896.7
Volume
189.7K

Price chart

Daily close · downsampled 5-year history

2021-06-21 · ₹6702026-06-18 · ₹906.9

Instrument details

MB Code
MBEQU1490
Type
stock
ISIN
INE659A01023
BSE
506655

Latest earnings

Q4FY26 declared

Quarter
Mar 2026
Revenue
2789.9 Cr
Net profit
82.5 Cr
EPS
10
YoY revenue
+106.75%

Price returns

Historical performance

1 day
+0.79%
1 month
+5.96%
3 months
+11.96%
1 year
-26.97%
3 years
+78.81%
5 years
+35.38%

Technicals

Indicator consensus

Bullish
24
Neutral
6
Bearish
16
RSI 58.38(Neutral)

Corporate timeline

Price chart events · 1 year

Dividend
2025-09-22
{"amount":4.5}
Earnings
2026-02-12
{"actualRevenue":21030000000,"estimateRevenue":24796000000,"revenueSurprise":-3766000000,"revenueSurprisePercent":-15.18793353766737,"actualEPS":-8.91,"estimateEPS":4.998,"surprise":-13.908,"surprisePercent":-278.2713085234094}
Earnings
2025-07-26
{"actualRevenue":13494390000,"estimateRevenue":7601000000,"revenueSurprise":5893390000,"revenueSurprisePercent":77.5344033679779,"actualEPS":7.6,"estimateEPS":7.191,"surprise":0.4089999999999998,"surprisePercent":5.687665136976774}
News
2025-09-25
{"description":"Sudarshan Chemical Industries Ltd reported a 295% surge in Q1 revenue, driven by the Heubach consolidation. This growth reflects strong performance and may positively impact investor sentiment towards the company's stock.","url":"https://www.thehindubusinessline.com/companies/sudarshan-chemicals-reports-295-surge-in-q1-revenue-on-heubach-consolidation/article70092669.ece","sentiment":"Positive","domain":"The Hindu BusinessLine"}
News
2025-09-24
{"description":"Sudarshan Chemical Industries Ltd's Q1 consolidated net profit surged 60.5% to ₹47.2 crore from ₹29.4 crore last year, driving its stock to an all-time high, indicating strong investor confidence and growth potential.","url":"https://www.business-standard.com/markets/news/sudarshan-chemical-share-price-nse-bse-q1-results-profit-ebitda-revenue-125092400245_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-06-20
{"description":"Sudarshan Pharma Industries, a small-cap specialty chemical firm, confirms a fundraising of up to Rs 1500 Cr and has incorporated a subsidiary in the US, attracting market attention.","url":"https://www.goodreturns.in/news/specialty-chemical-stock-sudarshan-pharma-confirms-fundraising-up-to-rs-1500-cr-incorporates-subsid-1437151.html","sentiment":"Positive","domain":"Goodreturns"}